-
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
Martin, Richard M; Turner, Emma L; Young, Grace J; Metcalfe, Chris; Walsh, Eleanor I; Lane, J Athene; Sterne, Jonathan A C; Noble, Sian; Holding, Peter; Ben-Shlomo, Yoav; Williams, Naomi J; Pashayan, Nora; Bui, Mai Ngoc; Albertsen, Peter C; Seibert, Tyler M; Zietman, Anthony L; Oxley, Jon; Adolfsson, Jan; Mason, Malcolm D; Davey Smith, George; Neal, David E; Hamdy, Freddie C; Donovan, Jenny L; CAP Trial Group JAMA 2024 Apr;
-
PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer.
Englman, Cameron; Maffei, Davide; Allen, Clare; Kirkham, Alex; Albertsen, Peter; Kasivisvanathan, Veeru; Baroni, Ronaldo Hueb; Briganti, Alberto; De Visschere, Pieter; Dickinson, Louise; Gómez Rivas, Juan; Haider, Masoom A; Kesch, Claudia; Loeb, Stacy; Macura, Katarzyna J; Margolis, Daniel; Mitra, Anita M; Padhani, Anwar R; Panebianco, Valeria; Pinto, Peter A; Ploussard, Guillaume; Puech, Philippe; Purysko, Andrei S; Radtke, Jan Philipp; Rannikko, Antti; Rastinehad, Art; Renard-Penna, Raphaele; Sanguedolce, Francesco; Schimmöller, Lars; Schoots, Ivo G; Shariat, Shahrokh F; Schieda, Nicola; Tempany, Clare M; Turkbey, Baris; Valerio, Massimo; Villers, Arnauld; Walz, Jochen; Barrett, Tristan; Giganti, Francesco; Moore, Caroline M European urology 2024 Mar;
-
Response to 'Endpoint and control group in prostate cancer screening research: public health basics'.
Albertsen, Peter C BJU international 2024 Mar;
-
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challenge.
Albertsen, Peter C; Bjerner, Lars Johan; Pasovic, Lara; Müller, Stig; Fosså, Sophie; Carlsson, Sigrid V; Oldenburg, Jan BJU international 2023 Oct;
-
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium.
Bjerner, Johan; Bratt, Ola; Aas, Kirsti; Albertsen, Peter C; Fosså, Sophie D; Kvåle, Rune; Lilja, Hans; Müller, Christoph; Müller, Stig; Stensvold, Andreas; Thomas, Owen; Røe, Oluf D; Vickers, Andrew; Walz, Jochen; Carlsson, Sigrid V; Oldenburg, Jan European urology 2023 May;
-
How many cores are enough? Optimizing the transperineal prostate biopsy template.
Schaufler, Christian; Daigle, Ryan; Singhaviranon, Summit; Gjertson, Carl K; Albertsen, Peter C; Ristau, Benjamin T Urol Oncol. 2022 May;
-
Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy.
Orrason, Andri Wilberg; Westerberg, Marcus; Albertsen, Peter; Styrke, Johan; Robinson, David; Garmo, Hans; Stattin, Pär PloS one 2022 Jan;17(11):e0277784
-
Prostate cancer screening: a new way forward or another false start?
Albertsen, Peter C Nature reviews. Urology 2021 Aug;
-
Re: Trends and practices for managing low-risk prostate cancer: A SEER-Medicare study.
Albertsen, Peter C Prostate cancer and prostatic diseases 2021 Jun;
-
Prostate cancer: the interplay between genetics and the environment.
Albertsen, Peter BJU international 2021 Jun;127(6):615-616
-
Prostate-specific Antigen Screening Using the Traditional Cut Point of 3 ng/ml: Con.
Albertsen, Peter C European urology focus 2021 Mar;
-
Prostate cancer screening and treatment: where have we come from and where are we going?
Albertsen, Peter C BJU international 2020 Aug;126(2):218-224
-
Re: Radical Prostatectomy or Watchful Waiting in Prostate Cancer-29-Year Follow-up.
Albertsen, Peter C European urology 2020 May;
-
Reconsidering Prostate Cancer Mortality - The Future of PSA Screening.
Welch, H Gilbert; Albertsen, Peter C The New England journal of medicine 2020 Apr;382(16):1557-1563
-
Estimating the threat posed by prostate cancer.
Albertsen, Peter C BJU international 2020 Apr;125(4):480-481
-
William Halsted and Prostate Cancer Progression.
Albertsen, Peter C European urology 2020 Mar;
-
The Evolving Paradigm of Prostate Cancer Screening.
Albertsen, Peter C JAMA network open 2019 Aug;2(8):e198392
-
Patient Decision-making: Where Are We Going?
Albertsen, Peter C European urology 2019 Jun;75(6):908-909
-
Centers of Excellence: What are Realistic Goals?
Albertsen, Peter C European urology 2019 Feb;
-
Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection: evolving experience with a 10-sector template.
Ristau, Benjamin T; Allaway, Matthew; Cendo, Demetri; Hart, John; Riley, Jason; Parousis, Vasil; Albertsen, Peter C Urologic oncology 2018 Dec;36(12):528.e15-528.e20
-
Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia.
Duan, Yinghui; Grady, James J; Albertsen, Peter C; Helen Wu, Z Pharmacoepidemiology and drug safety 2018 Jan;27340-348
-
Re: 10-Year Outcomes After Monitoring, Surgery or Radiotherapy for Localized Prostate Cancer.
Albertsen, Peter C European urology 2017 Sep;72(3):470
-
Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
Hoffman, Richard M; Lo, Mary; Clark, Jack A; Albertsen, Peter C; Barry, Michael J; Goodman, Michael; Penson, David F; Stanford, Janet L; Stroup, Antoinette M; Hamilton, Ann S Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 May;352306-2314
-
Risk Factors for Prostate Cancer: Which Are Truly Predictive of Clinically Significant Disease?
Albertsen, Peter C Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Dec;34(36):4310-4311
-
Validation of a Contemporary Five-tiered Gleason Grade Grouping Using Population-based Data.
He, Jianming; Albertsen, Peter C; Moore, Dirk; Rotter, David; Demissie, Kitaw; Lu-Yao, Grace European urology 2016 Dec;71760-763
-
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force.
Moore, Caroline M; Giganti, Francesco; Albertsen, Peter; Allen, Clare; Bangma, Chris; Briganti, Alberto; Carroll, Peter; Haider, Masoom; Kasivisvanathan, Veeru; Kirkham, Alex; Klotz, Laurence; Ouzzane, Adil; Padhani, Anwar R; Panebianco, Valeria; Pinto, Peter; Puech, Philippe; Rannikko, Antti; Renard-Penna, Raphaele; Touijera, Karim; Turkbey, Baris; van Poppel, Heinrik; Valdagni, Riccardo; Walz, Jochen; Schoots, Ivo European urology 2016 Jun;71648-655
-
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee.
Turner, Emma L; Metcalfe, Chris; Donovan, Jenny L; Noble, Sian; Sterne, Jonathan A C; Lane, J Athene; I Walsh, Eleanor; Hill, Elizabeth M; Down, Liz; Ben-Shlomo, Yoav; Oliver, Steven E; Evans, Simon; Brindle, Peter; Williams, Naomi J; Hughes, Laura J; Davies, Charlotte F; Ng, Siaw Yein; Neal, David E; Hamdy, Freddie C; Albertsen, Peter; Reid, Colette M; Oxley, Jon; McFarlane, John; Robinson, Mary C; Adolfsson, Jan; Zietman, Anthony; Baum, Michael; Koupparis, Anthony; Martin, Richard M British journal of cancer 2016 Jun;11590-4
-
Prostate specific antigen patterns in US and European populations: comparison of six diverse cohorts.
Simpkin, Andrew J; Donovan, Jenny L; Tilling, Kate; Lane, J Athene; Martin, Richard M; Albertsen, Peter C; Bill-Axelson, Anna; Carter, H Ballentine; Bosch, Ruud; Ferrucci, Luigi; Hamdy, Freddie C; Holmberg, Lars; Metter, E Jeffrey; Neal, David E; Parker, Christopher C; Metcalfe, Chris BJU international 2016 Jan;118911-918
-
Successful external validation of a model to predict other cause mortality in localized prostate cancer.
Kent, Matthew; Penson, David F; Albertsen, Peter C; Goodman, Michael; Hamilton, Ann S; Stanford, Janet L; Stroup, Antoinette M; Ehdaie, Behfar; Scardino, Peter T; Vickers, Andrew J BMC medicine 2016 Jan;14(1):25
-
Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.
Welch, H Gilbert; Gorski, David H; Albertsen, Peter C The New England journal of medicine 2015 Oct;373(18):1685-7
-
The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.
O'Neil, Brock; Koyama, Tatsuki; Alvarez, JoAnn; Conwill, Ralph M; Albertsen, Peter C; Cooperberg, Matthew R; Goodman, Michael; Greenfield, Sheldon; Hamilton, Ann S; Hoffman, Karen E; Hoffman, Richard M; Kaplan, Sherrie H; Stanford, Janet L; Stroup, Antoinette M; Paddock, Lisa E; Wu, Xiao-Cheng; Stephenson, Robert A; Resnick, Matthew J; Barocas, Daniel A; Penson, David F The Journal of urology 2015 Sep;195321-9
-
Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy.
Morgans, Alicia K; Fan, Kang-Hsien; Koyama, Tatsuki; Albertsen, Peter C; Goodman, Michael; Hamilton, Ann S; Hoffman, Richard M; Stanford, Janet L; Stroup, Antoinette M; Resnick, Matthew J; Barocas, Daniel A; Penson, David F The Journal of urology 2015 Apr;193(4):1226-31
-
Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.
Lu-Yao, Grace L; Albertsen, Peter C; Moore, Dirk F; Lin, Yong; DiPaola, Robert S; Yao, Siu-Long European urology 2015 Mar;68(5):805-11
-
Prostate-specific antigen testing: good or bad?
Albertsen, Peter C The oncologist 2015 Mar;20(3):233-5
-
Observational studies and the natural history of screen-detected prostate cancer.
Albertsen, Peter C Current opinion in urology 2015 Feb;25(3):232-7
-
Who and when should we screen for prostate cancer? Interviews with key opinion leaders.
Carlsson, Sigrid; Leapman, Michael; Carroll, Peter; Schröder, Fritz; Albertsen, Peter C; Ilic, Dragan; Barry, Michael; Frosch, Dominick L; Vickers, Andrew BMC medicine 2015 Jan;13288
-
Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study.
Daskivich, Timothy J; Fan, Kang-Hsien; Koyama, Tatsuki; Albertsen, Peter C; Goodman, Michael; Hamilton, Ann S; Hoffman, Richard M; Stanford, Janet L; Stroup, Antoinette M; Litwin, Mark S; Penson, David F Urology 2014 Sep;85(1):92-100
-
The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
Resnick, Matthew J; Barocas, Daniel A; Morgans, Alicia K; Phillips, Sharon E; Koyama, Tatsuki; Albertsen, Peter C; Cooperberg, Matthew R; Goodman, Michael; Greenfield, Sheldon; Hamilton, Ann S; Hoffman, Karen E; Hoffman, Richard M; Kaplan, Sherrie H; McCollum, Dan; Paddock, Lisa E; Stanford, Janet L; Stroup, Antoinette M; Wu, Xiao-Cheng; Penson, David F European urology 2014 Aug;67(6):1019-25
-
Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study.
Morgans, A K; Fan, K-H; Koyama, T; Albertsen, P C; Goodman, M; Hamilton, A S; Hoffman, R M; Stanford, J L; Stroup, A M; Penson, D F Prostate cancer and prostatic diseases 2014 Aug;17(4):338-42
-
Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.
Lu-Yao, Grace L; Albertsen, Peter C; Moore, Dirk F; Shih, Weichung; Lin, Yong; DiPaola, Robert S; Yao, Siu-Long JAMA internal medicine 2014 Jul;174(9):1460-7
-
Radical prostatectomy reduces prostate cancer-specific mortality among men with intermediate-grade disease, but provides minimal benefit for men with low-grade and high-grade disease.
Albertsen, Peter Evidence-based medicine 2014 Jun;19(5):176
-
Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop.
Jarow, Jonathan P; Thompson, Ian M; Kluetz, Paul G; Baxley, John; Sridhara, Rajeshwari; Scardino, Peter; Carroll, Peter; Albertsen, Peter; Carter, H Balentine; Brawley, Otis; Sartor, Oliver; Sandler, Howard; Kiefert, James J; Morton, Ronald A Urology 2014 Mar;83(5):975-8
-
Times, they are a-changing.
Albertsen, Peter C European urology 2013 Dec;66(3):428-9
-
Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist.
Albertsen, Peter C; Klotz, Laurence; Tombal, Bertrand; Grady, James; Olesen, Tine K; Nilsson, Jan European urology 2013 Nov;65(3):565-73
-
Words of wisdom: Re: Screening for prostate cancer: US Preventive Services Task Force recommendation statement.
Albertsen, Peter C European urology 2013 Sep;64(3):512
-
MRI before prostate biopsy--yes or no?
Albertsen, Peter C; Marks, Leonard S The Journal of urology 2013 Aug;190(6):1978-80
-
Timing of curative treatment for prostate cancer: a systematic review.
van den Bergh, Roderick C N; Albertsen, Peter C; Bangma, Chris H; Freedland, Stephen J; Graefen, Markus; Vickers, Andrew; van der Poel, Henk G European urology 2013 Aug;64(2):204-15
-
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer.
Daskivich, Timothy J; Fan, Kang-Hsien; Koyama, Tatsuki; Albertsen, Peter C; Goodman, Michael; Hamilton, Ann S; Hoffman, Richard M; Stanford, Janet L; Stroup, Antoinette M; Litwin, Mark S; Penson, David F Annals of internal medicine 2013 May;158(10):709-17
-
Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients.
Noon, A P; Albertsen, P C; Thomas, F; Rosario, D J; Catto, J W F British journal of cancer 2013 Apr;108(7):1534-40
-
It's time to change the treatment paradigm for prostate cancer!
Studer, Urs E; Albertsen, Peter C European urology 2013 Jan;63(1):97-9; discussion 99-100
-
Editorial comment: Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme.
Albertsen, Peter C BJU international 2012 Dec;110(11):1653
-
The prostate cancer conundrum revisited: further insights.
Albertsen, Peter Cancer 2012 Dec;118(23):5724-7
-
Editorial comment.
Albertsen, Peter C Urology 2012 Oct;80(4):888
-
Robot-assisted radical prostatectomy - fake innovation or the real deal?
Albertsen, Peter C European urology 2012 Sep;62(3):365-7
-
How best to use our tools?
Albertsen, Peter C European urology 2012 Aug;62(2):201-2; discussion 203
-
A tale of 2 perspectives: the clinician and the public health professional.
Albertsen, Peter Cancer 2012 Jun;118(12):3010-1
-
The timing and extent of androgen deprivation therapy for prostate cancer: weighing the clinical evidence.
Ginzburg, Serge; Albertsen, Peter C Endocrinology and metabolism clinics of North America 2011 Sep;40(3):615-23, ix
-
When is active surveillance the appropriate treatment for prostate cancer?
Albertsen, Peter C Acta oncologica (Stockholm, Sweden) 2011 Jun;50 Suppl 1120-6
-
WHO International Consultation on Prostate Cancer: a summary.
Albertsen, Peter C Acta oncologica (Stockholm, Sweden) 2011 Jun;50 Suppl 1155-60
-
Words of wisdom. Re: active surveillance compared with initial treatment in men with low-risk prostate cancer: a decision analysis.
Albertsen, Peter European urology 2011 May;59(5):882-3
-
Impact of comorbidity on survival among men with localized prostate cancer.
Albertsen, Peter C; Moore, Dirk F; Shih, Weichung; Lin, Yong; Li, Hui; Lu-Yao, Grace L Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Apr;29(10):1335-41
-
Use and assessment of PSA in prostate cancer.
Gjertson, Carl K; Albertsen, Peter C The Medical clinics of North America 2011 Jan;95(1):191-200
-
Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.
Stokes, M E; Black, L; Benedict, A; Roehrborn, C G; Albertsen, P Prostate cancer and prostatic diseases 2010 Sep;13(3):278-84
-
Reply
Albertsen P.C. Urology 2010 Jan;75(2):405-406
-
Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/mL
Shao Y.-H., Albertsen P.C., Roberts C.B., Lin Y., Mehta A.R., Stein M.N., DiPaola R.S., Lu-Yao G.L. Archives of Internal Medicine 2010 Jan;170(14):1256-1261
-
A statistical evaluation of rules for biochemical failure after radiotherapy in men treated for prostate cancer.
Bellera, Carine A; Hanley, James A; Joseph, Lawrence; Albertsen, Peter C International journal of radiation oncology, biology, physics 2009 Dec;75(5):1357-63
-
Outcomes of localized prostate cancer following conservative management.
Lu-Yao, Grace L; Albertsen, Peter C; Moore, Dirk F; Shih, Weichung; Lin, Yong; DiPaola, Robert S; Barry, Michael J; Zietman, Anthony; O'Leary, Michael; Walker-Corkery, Elizabeth; Yao, Siu-Long JAMA 2009 Sep;302(11):1202-9
-
Personalized prediction of tumor response and cancer progression on prostate needle biopsy.
Donovan, Michael J; Khan, Faisal M; Fernandez, Gerardo; Mesa-Tejada, Ricardo; Sapir, Marina; Zubek, Valentina Bayer; Powell, Douglas; Fogarasi, Stephen; Vengrenyuk, Yevgen; Teverovskiy, Mikhail; Segal, Mark R; Karnes, R Jeffrey; Gaffey, Thomas A; Busch, Christer; Haggman, Michael; Hlavcak, Peter; Freedland, Stephen J; Vollmer, Robin T; Albertsen, Peter; Costa, Jose; Cordon-Cardo, Carlos The Journal of urology 2009 Jul;182(1):125-32
-
First-year costs of treating prostate cancer: estimates from SEER-Medicare data.
Roehrborn, C G; Albertsen, P; Stokes, M E; Black, L; Benedict, A Prostate cancer and prostatic diseases 2009 Jan;12(4):355-60
-
Measuring illness uncertainty in men undergoing active surveillance for prostate cancer
Bailey Jr. D.E., Wallace M., Latini D.M., Hegarty J., Carroll P.R., Klein E.A., Albertsen P.C. Applied Nursing Research 2009 Jan;
-
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005
Welch H.G., Albertsen P.C. Journal of the National Cancer Institute 2009 Jan;101(19):1325-1329
-
Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up.
Lu-Yao, Grace; Albertsen, Peter C; Stanford, Janet L; Stukel, Therese A; Walker-Corkery, Elizabeth; Barry, Michael J Journal of general internal medicine 2008 Nov;23(11):1809-14
-
Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.
Ercole, Barbara; Marietti, Sarah R; Fine, Judith; Albertsen, Peter C The Journal of urology 2008 Oct;180(4):1336-9; discussion 1340-1
-
Survival following primary androgen deprivation therapy among men with localized prostate cancer.
Lu-Yao, Grace L; Albertsen, Peter C; Moore, Dirk F; Shih, Weichung; Lin, Yong; DiPaola, Robert S; Yao, Siu-Long JAMA 2008 Jul;300(2):173-81
-
The face of high risk prostate cancer.
Albertsen, Peter C World journal of urology 2008 Jun;26(3):205-10
-
Detecting trends in noisy data series: application to biomarker series.
Bellera, Carine A; Hanley, James A; Joseph, Lawrence; Albertsen, Peter C American journal of epidemiology 2008 May;167(9):1130-9
-
Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.
Collin, Simon M; Martin, Richard M; Metcalfe, Chris; Gunnell, David; Albertsen, Peter C; Neal, David; Hamdy, Freddie; Stephens, Peter; Lane, J Athene; Moore, Rollo; Donovan, Jenny The Lancet. Oncology 2008 May;9(5):445-52
-
Should men over the age of 65 years receive PSA screening? Argument against.
Albertsen, Peter C Nature clinical practice. Urology 2008 May;5(5):232-3
-
Hierarchical changepoint models for biochemical markers illustrated by tracking postradiotherapy prostate-specific antigen series in men with prostate cancer.
Bellera, Carine A; Hanley, James A; Joseph, Lawrence; Albertsen, Peter C Annals of epidemiology 2008 Apr;18(4):270-82
-
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.
Hussain, Sabina; Gunnell, David; Donovan, Jenny; McPhail, Sean; Hamdy, Freddie; Neal, David; Albertsen, Peter; Verne, Julia; Stephens, Peter; Trotter, Caroline; Martin, Richard M BJU international 2008 Mar;101(5):547-55
-
5-Year Urinary and Sexual Outcomes After Radical Prostatectomy: Results From the Prostate Cancer Outcomes Study
Penson D.F., McLerran D., Feng Z., Li L., Albertsen P.C., Gilliland F.D., Hamilton A., Hoffman R.M., Stephenson R.A., Potosky A.L., Stanford J.L. Journal of Urology 2008 Jan;179(5 SUPPL.):
-
Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of hospital episodes statistics for England.
Judge, Andrew; Evans, Simon; Gunnell, David J; Albertsen, Peter C; Verne, Julia; Martin, Richard M BJU international 2007 Nov;100(5):1040-9
-
13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
Albertsen, Peter C; Hanley, James A; Penson, David F; Barrows, George; Fine, Judith The Journal of urology 2007 Mar;177(3):932-6
-
Against the motion
Albertsen P. European Urology 2006 Jan;50(2):379-380
-
Prostate cancer and the Will Rogers phenomenon.
Albertsen, Peter C; Hanley, James A; Barrows, George H; Penson, David F; Kowalczyk, Pam D H; Sanders, M Melinda; Fine, Judith Journal of the National Cancer Institute 2005 Sep;97(17):1248-53
-
Prostate-specific antigen: how to advise patients as the screening debate continues.
Albertsen, Peter C Cleveland Clinic journal of medicine 2005 Jun;72(6):521-7
-
20-year outcomes following conservative management of clinically localized prostate cancer.
Albertsen, Peter C; Hanley, James A; Fine, Judith JAMA 2005 May;293(17):2095-101
-
Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation.
Albertsen, Peter C; Hanley, James A; Penson, David F; Fine, Judith The Journal of urology 2004 Jun;171(6 Pt 1):2221-5
-
Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.
Chakraborty, Nitya G; Stevens, Robert L; Mehrotra, Shikhar; Laska, Elizabeth; Taxel, Pamela; Sporn, Jonathan R; Schauer, Peter; Albertsen, Peter C Cancer immunology, immunotherapy : CII 2003 Aug;52(8):497-505
-
The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer.
Taxel, Pamela; Fall, Pamela M; Albertsen, Peter C; Dowsett, Robert D; Trahiotis, Margaret; Zimmerman, Jill; Ohannessian, Christine; Raisz, Lawrence G The Journal of clinical endocrinology and metabolism 2002 Nov;87(11):4907-13
-
United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
McNaughton Collins, Mary; Barry, Michael J; Zietman, Anthony; Albertsen, Peter C; Talcott, James A; Walker Corkery, Elizabeth; Elliott, Diana B; Fowler, Floyd J Urology 2002 Oct;60(4):628-33
-
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma.
Samson, David J; Seidenfeld, Jerome; Schmitt, Brian; Hasselblad, Vic; Albertsen, Peter C; Bennett, Charles L; Wilt, Timothy J; Aronson, Naomi Cancer 2002 Jul;95(2):361-76
-
Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom.
Penson, David F; Albertsen, Peter C Surgical oncology 2002 Jun;11(1-2):3-11
-
Effects of circumcision on male sexual function: debunking a myth?
Collins, S; Upshaw, J; Rutchik, S; Ohannessian, C; Ortenberg, J; Albertsen, P The Journal of urology 2002 May;167(5):2111-2
-
Nomograms for clinically localized disease. Part III: watchful waiting.
Schwartz, Eric; Albertsen, Peter Seminars in urologic oncology 2002 May;20(2):140-5
-
Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome.
Miller, Lauri J; Fischer, Kateri A; Goralnick, Sandra J; Litt, Mark; Burleson, Joseph A; Albertsen, Peter; Kreutzer, Donald L Urology 2002 Apr;59(4):603-8
-
Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome.
Miller, Lauri J; Fischer, Kateri A; Goralnick, Sandra J; Litt, Mark; Burleson, Joseph A; Albertsen, Peter; Kreutzer, Donald L The Journal of urology 2002 Feb;167(2 Pt 1):753-6
-
Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.
Harlan, L C; Potosky, A; Gilliland, F D; Hoffman, R; Albertsen, P C; Hamilton, A S; Eley, J W; Stanford, J L; Stephenson, R A Journal of the National Cancer Institute 2001 Dec;93(24):1864-71
-
Determining cause of death in prostate cancer: are death certificates valid?
Penson, D F; Albertsen, P C; Nelson, P S; Barry, M; Stanford, J L Journal of the National Cancer Institute 2001 Dec;93(23):1822-3
-
Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis.
Barry, M J; Albertsen, P C; Bagshaw, M A; Blute, M L; Cox, R; Middleton, R G; Gleason, D F; Zincke, H; Bergstralh, E J; Jacobsen, S J Cancer 2001 Jun;91(12):2302-14
-
Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer.
Sneeuw, K C; Albertsen, P C; Aaronson, N K The Journal of urology 2001 Feb;165(2):478-82
-
Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
Potosky, A L; Legler, J; Albertsen, P C; Stanford, J L; Gilliland, F D; Hamilton, A S; Eley, J W; Stephenson, R A; Harlan, L C Journal of the National Cancer Institute 2000 Oct;92(19):1582-92
-
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
Fowler, F J; McNaughton Collins, M; Albertsen, P C; Zietman, A; Elliott, D B; Barry, M J JAMA 2000 Jun;283(24):3217-22
-
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.
Stanford, J L; Feng, Z; Hamilton, A S; Gilliland, F D; Stephenson, R A; Eley, J W; Albertsen, P C; Harlan, L C; Potosky, A L JAMA 2000 Jan;283(3):354-60
-
Expression of vascular endothelial growth factor receptors in human prostate cancer.
Ferrer, F A; Miller, L J; Lindquist, R; Kowalczyk, P; Laudone, V P; Albertsen, P C; Kreutzer, D L Urology 1999 Sep;54(3):567-72
-
Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy--a population-based study.
Lu-Yao, G L; Albertsen, P; Warren, J; Yao, S L Urology 1999 Aug;54(2):301-7
-
Economic analysis of finasteride: a model-based approach using data from the Proscar Long-Term Efficacy and Safety Study.
Albertsen, P C; Pellissier, J M; Lowe, F C; Girman, C J; Roehrborn, C G Clinical therapeutics 1999 Jun;21(6):1006-24
-
Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms: Editorial comment
Albertsen P.C. Journal of Urology 1999 Jan;161(4 SUPPL.):1188
-
Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer.
Albertsen, P C; Hanley, J A; Gleason, D F; Barry, M J JAMA 1998 Sep;280(11):975-80
-
Image analysis combined with visual cytology in the early detection of recurrent bladder carcinoma.
Richman, A M; Mayne, S T; Jekel, J F; Albertsen, P Cancer 1998 May;82(9):1738-48
-
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.
McConnell, J D; Bruskewitz, R; Walsh, P; Andriole, G; Lieber, M; Holtgrewe, H L; Albertsen, P; Roehrborn, C G; Nickel, J C; Wang, D Z; Taylor, A M; Waldstreicher, J The New England journal of medicine 1998 Feb;338(9):557-63
-
Assessment of the feasibility and impact of shared decision making in prostate cancer.
Onel, E; Hamond, C; Wasson, J H; Berlin, B B; Ely, M G; Laudone, V P; Tarantino, A E; Albertsen, P C Urology 1998 Jan;51(1):63-6
-
Prostate disease in older men: 2. Cancer.
Albertsen, P C Hospital practice (1995) 1997 Oct;32(10):159-66, 171, 175-6 passim
-
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.
Ferrer, F A; Miller, L J; Andrawis, R I; Kurtzman, S H; Albertsen, P C; Laudone, V P; Kreutzer, D L The Journal of urology 1997 Jun;157(6):2329-33
-
Prostate disease in older men: 1. Benign hyperplasia.
Albertsen, P C Hospital practice (1995) 1997 May;32(5):61-4, 67-8, 77 passim
-
Health-related quality of life among patients with metastatic prostate cancer.
Albertsen, P C; Aaronson, N K; Muller, M J; Keller, S D; Ware, J E Urology 1997 Feb;49(2):207-16; discussion 216-7
-
Temporal trends in rates of prostate cancer: Declining incidence of advanced stage disease, 1974 to 1994. Editorial comment
Albertsen P.C. Journal of Urology 1997 Jan;158(4):1430
-
The impact of co-morbidity on life expectancy among men with localized prostate cancer.
Albertsen, P C; Fryback, D G; Storer, B E; Kolon, T F; Fine, J The Journal of urology 1996 Jul;156(1):127-32
-
Estimating treatment benefits for the elderly: the effect of competing risks.
Welch, H G; Albertsen, P C; Nease, R F; Bubolz, T A; Wasson, J H Annals of internal medicine 1996 Mar;124(6):577-84
-
Follow-up prostate cancer treatments after radical prostatectomy: a population-based study.
Lu-Yao, G L; Potosky, A L; Albertsen, P C; Wasson, J H; Barry, M J; Wennberg, J E Journal of the National Cancer Institute 1996 Feb;88(3-4):166-73
-
Prostate biopsy in the community: who are the most likely candidates?
Albertsen, P; Fine, J Contemporary urology 1995 Feb;7(2):54-7
-
Long-term survival among men with conservatively treated localized prostate cancer.
Albertsen, P C; Fryback, D G; Storer, B E; Kolon, T F; Fine, J JAMA 1995 Jan;274(8):626-31
-
Computer modeling and decision making: clinical applications in bladder cancer.
Albertsen, P C Seminars in urology 1993 Aug;11(3):171-6
-
Building population data bases: lessons from a community project.
Albertsen, P C; Fine, J Clinical performance and quality health care 1993 Jan;1(4):191-3
-
Variations in coding practices among Connecticut urologists for the Medicare population.
Albertsen, P C; Kamens, E A Connecticut medicine 1990 Sep;54(9):508-11